Elicio Therapeutics, Inc. (ELTX) earnings
Quarterly results of Elicio Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Elicio Therapeutics, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Elicio Therapeutics, Inc. reported revenue of - and a net loss of $8.2M.
Diluted earnings per share were -$0.43.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$8.2M | -$0.43 |
| Q1 FY2026 | - | - | -$11.8M | -$0.65 |
| Q4 FY2025 | - | - | -$7.7M | - |
| Q3 FY2025 | - | - | -$10.1M | -$0.60 |
| Q2 FY2025 | - | - | -$10.6M | -$0.66 |
| Q1 FY2025 | - | - | -$11.2M | -$0.87 |
| Q4 FY2024 | - | - | -$14M | - |
| Q3 FY2024 | - | - | -$18.8M | -$1.39 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report (amended) 10-K/A
- Annual report 10-K
- Quarterly results 8-K
When is Elicio Therapeutics, Inc.'s next earnings date?
Elicio Therapeutics, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Get an email when ELTX reports
Follow ELTX and we email you its next results the day they are filed, with the numbers explained.